Healthcare provider profile · identity verified

Jonathan James Blaza, MD

Family Practice · ENGLEWOOD, OH · NPI 1245625359

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	769	174
Levothyroxine Sodium	Levothyroxine Sodium	461	104
Metformin Hcl	Metformin Hcl	402	86
Amlodipine Besylate	Amlodipine Besylate	377	94
Losartan Potassium	Losartan Potassium	262	64
Lisinopril	Lisinopril	249	67
Omeprazole	Omeprazole	237	72
Potassium Chloride	Potassium Chloride	196	29
Tamsulosin Hcl	Tamsulosin Hcl	186	50
Hydrochlorothiazide	Hydrochlorothiazide	176	49
Sertraline Hcl	Sertraline Hcl	173	34
Gabapentin	Gabapentin	165	31
Simvastatin	Simvastatin	162	29
Fluticasone Propionate	Fluticasone Propionate	151	41
Pantoprazole Sodium	Pantoprazole Sodium	135	36
Albuterol Sulfate Hfa	Albuterol Sulfate	133	33
Metoprolol Succinate	Metoprolol Succinate	119	35
Furosemide	Furosemide	113	27
Ozempic	Semaglutide	108	21
Allopurinol	Allopurinol	105	22
Duloxetine Hcl	Duloxetine Hcl	105	23
Lamotrigine	Lamotrigine	104	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	102	21
Metformin Hcl Er	Metformin Hcl	97	33
Escitalopram Oxalate	Escitalopram Oxalate	91	14
Trazodone Hcl	Trazodone Hcl	91	24
Citalopram Hbr	Citalopram Hydrobromide	90	18
Rosuvastatin Calcium	Rosuvastatin Calcium	82	26
Aripiprazole	Aripiprazole	81	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	81	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	81	15
Famotidine	Famotidine	75	19
Montelukast Sodium	Montelukast Sodium	74	17
Buspirone Hcl	Buspirone Hcl	67	19
Pravastatin Sodium	Pravastatin Sodium	66	20
Diclofenac Sodium	Diclofenac Sodium	64	20
Eliquis	Apixaban	64	12
Oxybutynin Chloride Er	Oxybutynin Chloride	64	13
Levetiracetam	Levetiracetam	63	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	17
Glipizide	Glipizide	61	16
Farxiga	Dapagliflozin Propanediol	59	11
Fluoxetine Hcl	Fluoxetine Hcl	59	15
Clopidogrel	Clopidogrel Bisulfate	58	14
Baclofen	Baclofen	57	suppressed
Glimepiride	Glimepiride	57	15
Lovastatin	Lovastatin	57	11
Alendronate Sodium	Alendronate Sodium	56	20
Carvedilol	Carvedilol	56	15
Methocarbamol	Methocarbamol	54	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	15
Mirtazapine	Mirtazapine	49	suppressed
Topiramate	Topiramate	48	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	14
Tizanidine Hcl	Tizanidine Hcl	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Meloxicam	Meloxicam	40	12
Ezetimibe	Ezetimibe	39	14
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Clonidine Hcl	Clonidine Hcl	36	suppressed
Divalproex Sodium Er	Divalproex Sodium	36	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Spironolactone	Spironolactone	34	suppressed
Atenolol	Atenolol	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Ibuprofen	Ibuprofen	31	11
Jardiance	Empagliflozin	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Naproxen	Naproxen	31	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	29
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	suppressed
Finasteride	Finasteride	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Ketoconazole	Ketoconazole	26	11
Lactulose	Lactulose	24	suppressed
Myrbetriq	Mirabegron	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Fenofibrate	Fenofibrate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Primidone	Primidone	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	18	14
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Prednisone	Prednisone	15	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Metolazone	Metolazone	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Gemtesa	Vibegron	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Glipizide Er	Glipizide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error